piracetam has been researched along with Alpers Diffuse Degeneration of Cerebral Gray Matter with Hepatic Cirrhosis in 1 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chouinard, G | 1 |
| Annable, L | 1 |
| Ross-Chouinard, A | 1 |
| Olivier, M | 1 |
| Fontaine, F | 1 |
1 other study available for piracetam and Alpers Diffuse Degeneration of Cerebral Gray Matter with Hepatic Cirrhosis
| Article | Year |
|---|---|
A double-blind, placebo-controlled study of piracetam in elderly psychiatric patients [proceedings].
Topics: Aged; Diffuse Cerebral Sclerosis of Schilder; Double-Blind Method; Humans; Intelligence; Memory; Pir | 1981 |